Journal
EXPERT REVIEW OF VACCINES
Volume 14, Issue 7, Pages 913-915Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2015.1046440
Keywords
antigen platform; retrovirus; RTS; S; vaccine development; virus-like particles
Categories
Ask authors/readers for more resources
The techniques to produce effective vaccines have evolved, and the early vaccines (live, inactivated, subunit...) are no longer considered as the most appropriate for new vaccine development. We question here what will be the future vaccines, and argue that virus-like particle (VLP)-based vaccines are promising candidates. In addition to being effective vaccines against analogous viruses from which they are derived, VLPs can also be used to present foreign epitopes to the immune system. The achievement of this strategy can be illustrated by the recent development of malaria candidate vaccine. We point out recent VLP-based vaccine developments and discuss future perspectives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available